Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis
免疫检查点抑制剂时代霍奇金淋巴瘤异基因造血干细胞移植的疗效:CIBMTR 和 EBMT 联合分析
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2024027197
Perales, Miguel-Angel; Awan, Farrukh T; Boumendil, Ariane; Patel, Jinalben; Castagna, Luca; Angelucci, Emanuele; Finel, Herve; Kulagin, Alexander; Glass, Bertram; Corradini, Paolo; Herrera, Alex F; Blaise, Didier; Kharfan-Dabaja, Mohamed A; Halahleh, Khalid; Ahmed, Sairah; Martínez, Carmen; Giebel, Sebastian; Montoto, Silvia; Jones, Richard J; Ahmed, Nausheen; Lynch, Ryan C; De Lima, Marcos J; Shadman, Mazyar; Sauter, Craig S; Ahn, Kwang W; Hamadani, Mehdi; Bazarbachi, Ali; Sureda, Anna